Transcatheter Closure of Patent Foramen Ovale Associated with Paradoxical Embolism Using the Amplatzer PFO Occluder: Initial and Intermediate-Term Results of the U.S. Multicenter Clinical Trial

Catheterization and Cardiovascular Interventions

Volumn 60, Issue 4, 2003, Pages 524-528

  Hong, Thomas E ^a   Thaler, David ^b   Brorson, James ^c   Heitschmidt, Mary ^a   Hijazi, Ziyad M ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b TUFTS MEDICAL CENTER   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

Author keywords

Device; Paradoxical; Stroke; Transient ischemic attack

Indexed keywords

ADOLESCENT; ADULT; ANEURYSM; ARTERIOVENOUS FISTULA; ARTERY EMBOLISM; ARTICLE; BIOSAFETY; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; DEVICE; FEMALE; FLUOROSCOPY; FOLLOW UP; HEART ARRHYTHMIA; HEART ATRIUM SEPTUM DEFECT; HEART CATHETER; HEART PALPITATION; HUMAN; MALE; OPERATION DURATION; PARADOXICAL EMBOLISM; TRANSIENT ISCHEMIC ATTACK; VERTIGO;

ADULT; EMBOLISM; FEMALE; HEART CATHETERIZATION; HEART SEPTAL DEFECTS, ATRIAL; HUMANS; ISCHEMIC ATTACK, TRANSIENT; MALE; TREATMENT OUTCOME; UNITED STATES;

EID: 0345707563     PISSN: 15221946     EISSN: None     Source Type: Journal    
DOI: 10.1002/ccd.10674     Document Type: Article

References (29)

1. Lechat P, Mas JL, Lascault G, Loron P, Theard M, Klimczac M, Drobinski G, Thomas D, Grosgogeat Y. Prevalence of patent foramen ovale in patients with stroke. N Engl J Med 1988;318:1148-1152.
2. Webster MW, Chancellor AM, Smith HJ, Swift DL, Sharpe DN, Bass NM, Glasgow GL. Patent foramen ovale in young stroke patients. Lancet 1988;2:11-12.
3. Di Tullio M, Sacco RL, Gopal A, Mohr JP, Homma S. Patent foramen ovale as a risk factor for cryptogenic stroke. Ann Intern Med 1992;117:461-465.
4. Bogousslavsky J, Garazi S, Jeanrenaud X, Aebischer N. Van Melle G, Lausanne Stroke With Paradoxical Embolism Study Group. Stroke recurrence in patients with a patent foramen ovale: the Lausanne study. Neurology 1996;46:1301-1305.
5. Hausmann D, Mugge A, Becht I, Daniel WG. Diagnosis of patent foramen ovale by transesophageal echocardiography and association with cerebral and peripheral embolic events. Am J Cardiol 1992;70:669-672.
6. Cabanes L, Mas JL, Cohen A, Amarenco P, Cabanes PA, Oubary P, Chedru F, Guerin F, Bousser MG, de Recondo J. Atrial septal aneurysm and patent foramen ovale as risk factors for cryptogenic stroke in patients less than 55 years of age: a study using transesophageal echocardiography. Stroke 1993;24:1865-1873.
7. Mas JL, Zuber M. French Study Group on Patent Foramen Ovale and Atrial Septal Aneurysm: recurrent cerebrovascular events in patients with patent foramen ovale, atrial septal aneurysm, or both and cryptogenic stroke or transient ischemic attack. Am Heart J 1995;130:1083-1088.
8. French Study Group on Patent Foramen Ovale and Atrial Septal Aneurysm. Recurrent cerebrovascular events in patients with PFO and ASA and cryptogenic stroke and TIA. Am Heart J 1995;130:1083-1088.
9. Stone DA, Godard J, Coretti MC, Kittner SJ, Sample C, Price TR, Plotnick GD. Patent foramen ovale: association between the degree of shunt by contrast transesophageal echocardiography and the risk of future ischemic neuologic events. Am Heart J 1996;131:158-161.
10. De Castro S, Cartoni D, Fiorelli M, Rasura M, Anzini A, Zanette EM, Beccia M, Colonnese C, Fedele F, Fieschi C, Pandian NG. Morphological and functional characterisitics of patent foramen ovale and their embolic implications. Stroke 2000;31:2407-2413.
11. Stroke Prevention in Atrial Fibrillation II Study. Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation. Lancet 1994;343:687-691.
12. Homma S, Di TM, Sacco RL, Sciacca RR, Smith C, Mohr JP. Surgical closure of patent foramen ovale in cryptogenic stroke patients. Stroke 1997;28:2376-2381.
13. Ruchat P, Bogousslavsky J, Hurni M, Fischer AP, Jeanrenaud X, von Segesser LK. Systematic surgical closure of patent foramen ovale in selected patients with cerebrovascular events due to paradoxical embolism: early results of a preliminary study. Eur J Cardiothorac Surg 1997;11:824-827.
14. Dearani JA, Ugurlu BS, Danielson GK, Daly RC, McGregor CG, Mullany CJ, Puga FJ, Orszulak TA, Anderson BJ, Brown RD Jr, Schaff HV. Surgical patent foramen ovale closure for prevention of paradoxical embolism-related cerebrovascular ischemic events. Circulation 1999;100(Suppl 2):II171-II175.
15. Waight DJ, Cao QL, Hijazi ZM. Closure of patent foramen ovale in patients with orthodeoxia-platypnea using the Amplatzer devices. Cathet Cardiovasc Intervent 2000;50:195-198.
16. Bridges ND, Hellenbrand W, Latson L, Filiano J, Newburger JW, Lock JE. Transcatheter closure of patent foramen ovale after presumed paradoxical embolism. Circulation 1992;86:1902-1908.
17. Ende DJ, Chopra PS, Rao PS. Transcatheter closure of atrial septal defect or patent foramen ovale with the buttoned device for prevention of recurrence of paradoxical embolism. Am J Cardiol 1996;78:233-236.
18. Sievert H, Babic UU, Hausdorf G, Schneider M, Hopp HW, Pfieffer D, Pfisterer M, Friedle B, Urban P. Transcatheter closure of atrial septal defect and patent foramen ovale with ASDOS device (a multi-institutional European trial). Am J Cardiol 1998;82:1405-1413.
19. Windecker S, Wahl A, Chatterjee, Garachemani A, Eberli RF, Seiler C, Meier B. Percutaneous closure of patent foramen ovale in patients with paradoxical embolism: long-term risk of recurrent thromboembolic events. Circulation 2000;101:893-898.
20. Hung J, Landzberg MJ, Jenkins KJ, King ME, Lock JE, Palacios IF, Lang P. Closure of patent foramen ovale for paradoxical emboli: intermediate-term risk of recurrent neurological events following transcatheter device placement. J Am Coll Cardiol 2000;35:1311-1316.
21. Butera G, Bini MR, Chessa M, Bedogni F, Onofri M, Carminati M. Transcatheter closure of patent foramen ovale in patients with cryptogenic stroke. Ital Heart J 2001;2:115-118.
22. Sievert H, Horvath K, Zadan E, Krumsdorf U, Fach A, Merle H, Scherer D, Schrader R, Spies H, Nowak B, Lissmann-Jensen H. Patent foramen ovale closure in patients with transient ischemia attack/stroke. J Intervent Cardiol 2001;14:261-266.
23. Wahl A, Windecker S, Eberli FR, Sieler C, Meier B. Percutaneous closure of patent foramen ovale in symptomatic patients. J Intervent Cardiol 2001;14:203-209.
24. Beitzke A, Schuchlenz H, Gamillscheg A, Stein JI, Wendelin G. Catheter closure of the patent foramen ovale: mid-term results in 162 patients. J Intervent Cardiol 2001;14:223-229.
25. Martin F, Sanchez PL, Doherty E, Colon-Hemandez PJ, Delgado G, Inglessis I, Scott N, Hung J, King ME, Buonanno F, Demirjian Z, de Moor M, Palacios IF. Percutaneous transcatheter closure of patent foramen ovale in patients with paradoxical embolism. Circulation 2002;106:1121-1126.
26. Braun MU, Fassbender D, Schoen SP, Haass M, Schraeder R, Scholtz W, Strasser RH. Transcatheter closure of patent foramen ovale in patients with cerebral ischemia. J Am Coll Cardiol 2002;39:2019-2025.
27. Du ZD, Cao QL, Joseph A, Koenig P, Heischmidt M, Waight DJ, Rhodes J, Brorson J, Hijazi ZM. Transcatheter closure of patent foramen ovale in patients with paradoxical embolism: intermediate-term risk of recurrent neurological events. Cathet Cardiovasc Intervent 2002;55:189-194.
28. Bruch L, Parsi A, Grad MO, Rux S, Burmeister T, Krebs H, Kleber FX. Transcatheter closure of interatrial communications for secondary prevention of paradoxical embolism. Circulation 2002;105:2845-2848.
29. Mas JL, Arquizan C, Lamy C, Zuber M, Cabanes L, Derumeaux G, Coste J. Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N Engl J Med 2001;345:1740-1746.